These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10900252)

  • 1. Pharmacokinetics of sodium tungstate in rat and dog: a population approach.
    Le Lamer S; Poucheret P; Cros G; de Richter RK; Bonnet PA; Bressolle F
    J Pharmacol Exp Ther; 2000 Aug; 294(2):714-21. PubMed ID: 10900252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of food and diabetes on pharmacokinetics of sodium tungstate in rat.
    Le Lamer-Déchamps S; Poucheret P; Cros G; Bressolle F
    Int J Pharm; 2002 Nov; 248(1-2):131-9. PubMed ID: 12429467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in beagle dogs.
    Le Lamer S; Cros G; Serrano JJ; Piñol C; Fernändez-Alvarez J; Bressolle F
    Eur J Pharm Sci; 2001 Dec; 14(4):323-9. PubMed ID: 11684407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of radiolabeled tungsten ((188)W) in male Sprague-Dawley rats following acute sodium tungstate inhalation.
    Radcliffe PM; Leavens TL; Wagner DJ; Olabisi AO; Struve MF; Wong BA; Tewksbury E; Chapman GD; Dorman DC
    Inhal Toxicol; 2010 Jan; 22(1):69-76. PubMed ID: 20017594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats.
    Le Lamer S; Cros G; Piñol C; Fernández-Alvarez J; Bressolle F
    Pharmacol Toxicol; 2002 Feb; 90(2):100-5. PubMed ID: 12071424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and clearance of tungsten after single-dose oral and intravenous exposure in rodents.
    McDonald JD; Weber WM; Marr R; Kracko D; Khain H; Arimoto R
    J Toxicol Environ Health A; 2007 May; 70(10):829-36. PubMed ID: 17454559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and intravenous trichloroethylene pharmacokinetics in the rat.
    D'Souza RW; Bruckner JV; Feldman S
    J Toxicol Environ Health; 1985; 15(5):587-601. PubMed ID: 4046066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biospeciation of tungsten in the serum of diabetic and healthy rats treated with the antidiabetic agent sodium tungstate.
    Gómez-Gómez MM; Rodríguez-Fariñas N; Cañas-Montalvo B; Domínguez J; Guinovart J; Cámara-Rica C
    Talanta; 2011 May; 84(4):1011-8. PubMed ID: 21530773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
    Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
    Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog. Interspecies relationship comparing with human pharmacokinetics.
    Påhlman I; Kankaanranta S; Palmér L
    Arzneimittelforschung; 2001 Feb; 51(2):134-44. PubMed ID: 11258043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of pirtenidine in the rat and dog.
    Powles P; Usansky JI; Franklin RA
    Xenobiotica; 1989 Dec; 19(12):1349-54. PubMed ID: 2618086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
    Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
    J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
    Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
    Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats.
    Sánchez-González M; Colom H; Lozano-Mena G; Juan ME; Planas JM
    Mol Nutr Food Res; 2014 Oct; 58(10):1970-9. PubMed ID: 25045029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia.
    Aydemir M; Ozturk N; Dogan S; Aslan M; Olgar Y; Ozdemir S
    Biol Trace Elem Res; 2012 Aug; 148(2):216-23. PubMed ID: 22351103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.